J&J One-Shot Covid Vaccine Expects to Get FDA’s Approval for Emergency Use on Friday!

FDA’s staff endorsed J&J’s single-shot Covid-19 vaccine for emergency use as the jab showed positive results in moderate and severe cases.

The Food and Drug Administration (FDA)’s staff endorsed Johnson & Johnson (J&J)’s Covid-19 vaccine for emergency use as the jab showed positive results in moderate and severe cases.

 

J&J’s vaccine showed 86% efficacy against severe forms of Covid-19 in the United States, and 82% against severe variants in South Africa.

FDA’s Vaccines and Related Biological Products Advisory Committee will meet on Friday to review J&J’s request for emergency use of its vaccine.

 

More importantly, J&J’s vaccine requires only one dose, making logistics much easier as well as more convenient for the patients.